NYSE: EHABEnhabit Inc Stock
$14.41-0.69 (-4.57%)
Updated Feb 6, 2023
EHAB Price
$14.41
Fair Value Price
N/A
Market Cap
$715.00M
52 Week Low
$11.65
52 Week High
$23.51
P/E
N/A
P/B
0.86x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.91
Operating Cash Flow
N/A
Beta
0.58
Next Earnings
Feb 14, 2023
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EHAB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EHAB is good value based on its book value relative to its share price (0.86x), compared to the US Medical Care Facilities industry average (4.8x)
P/B vs Industry Valuation
EHAB's short-term assets ($225.70M) exceed its short-term liabilities ($150.30M)
Short-term Liabilities Financials
EHAB's long-term liabilities ($608.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more EHAB due diligence checks available for Premium users.
Be the first to know about important EHAB news, forecast changes, insider trades & much more!
EHAB News
Valuation
EHAB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.86x
Industry
4.8x
EHAB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EHAB's financial health
Profit margin
Revenue
$265.7M
Net Income
$8.6M
Profit Margin
3.2%
Assets to liabilities
Assets
$1.6B
Liabilities
$759.1M
Debt to equity
0.91
EHAB's short-term assets ($225.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EHAB's long-term liabilities ($608.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EHAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.0M
Investing
-$600.0k
Financing
-$6.2M
EHAB vs Medical Care Facility Stocks
Enhabit Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.